Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015870
Filing Date
2021-11-15
Accepted
2021-11-15 07:36:43
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q thrx-20210930x10q.htm   iXBRL 10-Q 2230022
2 EX-3.1 thrx-20210930xex3d1.htm EX-3.1 248722
3 EX-3.2 thrx-20210930xex3d2.htm EX-3.2 59823
4 EX-31.1 thrx-20210930xex31d1.htm EX-31.1 14943
5 EX-31.2 thrx-20210930xex31d2.htm EX-31.2 15172
6 EX-32.1 thrx-20210930xex32d1.htm EX-32.1 8036
7 EX-32.2 thrx-20210930xex32d2.htm EX-32.2 8043
8 GRAPHIC thrx-20210930xex3d1001.jpg GRAPHIC 3500
  Complete submission text file 0001558370-21-015870.txt   7411489

Data Files

Seq Description Document Type Size
9 EX-101.SCH thrx-20210930.xsd EX-101.SCH 45594
10 EX-101.CAL thrx-20210930_cal.xml EX-101.CAL 29186
11 EX-101.DEF thrx-20210930_def.xml EX-101.DEF 201172
12 EX-101.LAB thrx-20210930_lab.xml EX-101.LAB 397399
13 EX-101.PRE thrx-20210930_pre.xml EX-101.PRE 329108
14 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20210930x10q_htm.xml XML 999063
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 211406359
SIC: 2834 Pharmaceutical Preparations